Chemotherapy of fungal diseases

20

Transcript of Chemotherapy of fungal diseases

Page 1: Chemotherapy of fungal diseases
Page 2: Chemotherapy of fungal diseases
Page 3: Chemotherapy of fungal diseases

INTRODUCTIONINTRODUCTION

Page 4: Chemotherapy of fungal diseases

DEFENITION:DEFENITION: An antifungal agent is a drug that An antifungal agent is a drug that selectively eliminates fungal pathogens from a host with selectively eliminates fungal pathogens from a host with

minimal toxicity to the.minimal toxicity to the.

Fungal infections classification: Superficial infections:

Ringworm (tinea) → skin and mucous membrane. Incidence

rate is high.

Systemic infections: Candida albicans → opportunist infections.

. Fatality rate is high.

Page 5: Chemotherapy of fungal diseases
Page 6: Chemotherapy of fungal diseases

TREATMENTTREATMENT

Page 7: Chemotherapy of fungal diseases

Amphotericin BAmphotericin B Produced by Streptomyces nodosus.

Amphoteric polyene macrolide. Mechanism: binds to ergosterol in

fungi (cholesterol in humans and bacteria) to form pores

Pharmacokinetics:

Page 8: Chemotherapy of fungal diseases

Adverse Effect :

Infusion-Related Toxicity: fever, chills, muscle spasms, vomiting, headache, hypotension.

Slower Toxicity: Renal toxicity, K+↓, Mg2+↓.

Anemia: erythropoietin Abnormalities of liver function

Neurologic sequela

Page 9: Chemotherapy of fungal diseases

NystatinMechanism : Like Amphotericin B and has same mechanism of action. Adverse effects : Too toxic for parenteral

administration, and is only used topically.

Griseofulvin

Page 10: Chemotherapy of fungal diseases

AzolesAzoles Synthetic compounds. Classification: according to the number of

nitrogen atoms in the five-membered azole ring Imidazoles: Ketoconazole, Miconazole, Econazole,

Clotrimazole, Bifonazole Triazoles: Itraconazole, Fluconazol, Vorionazole →

systemic treatment

Mechanism of Action

Reduction of ergosterol synthesis by inhibition of fungal cytochrome P450 enzymes.Greater affinity for funfal than for human cytochrome P450 enzymes.Imidazoles exhibit a lesser degree of specificity than the triazoles, accounting for their higher incidence of drug interactions and side effects

Page 11: Chemotherapy of fungal diseases

KetoconazoleKetoconazole The first oral azole introduced into clinical use. Less selective for fungal P450

Inhibition of human P450 interferes with biosynthesis of adrenal and gonadal steroid hormones;

Alter the metabolism of other drugs. Best absorbed at a low gastric pH.

Miconazole, Econazole, ClotrimazoleBioavailability is low by taking orally. Used topically.

Page 12: Chemotherapy of fungal diseases

Itraconazole

Treatment of dermatophytoses and onychomycosis

The only agent with significant activity against aspergillus species.

Fluconazole

Page 13: Chemotherapy of fungal diseases

VorionazolVorionazolee

Metabolism is predominantly hepatic. Similar to itraconazole in its spectrum

of action, having good activity against candida species.

More effective than itraconazole.

Page 14: Chemotherapy of fungal diseases

AllylaminesAllylamines Allyl amines inhibit the enzyme

squaleneepoxidase, another enzyme required for

ergosterol synthesis: Terbinafine - marketed as Lamisil Amorolfine Naftifine Butenafine

Page 15: Chemotherapy of fungal diseases

EchinocaEchinocandinndin

Echinocandins inhibit the synthesis of glucan in the cell wall, probably via the enzyme 1,3-βglucan synthase

Anidulafungin Caspofungin

Page 16: Chemotherapy of fungal diseases

Pyrimidine Flucytosine ( 5-FC ) is a water-

soluble pyrimidine analog. Its spectrum of action is much

narrower than that of amphotericin B. Poorly protein-bound and penetrates

well into all body fluid aompartments, including the cerebrospinal fluid.

Page 17: Chemotherapy of fungal diseases

Mechanism 5-FC (taken up by fungal cells via the

enzyme cytosine permease) → 5-FU → F-dUMP and FUTP → inhibit DNA and RNA synthesis, respectively.

Adverse effects: result from metabolism to fluorouracil (5-FU) Bone marrow toxicity with anemia,

leukopenia, and thrombocytopenia

Page 18: Chemotherapy of fungal diseases

CONCLUSION:CONCLUSION:

Page 19: Chemotherapy of fungal diseases

REFERENCESREFERENCES::

Page 20: Chemotherapy of fungal diseases